ArticleBMC pediatrics2026
Management of patients requiring high-flow nasal cannula in a pediatric observation unit: a single-center experience.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDue to widespread shortages of pediatric intensive care unit (PICU) beds during the 2022–2023 respiratory virus surge, a protocol was implemented to identify and manage patients on high-flow nasal cannula (HFNC) in a pediatric observation unit (POU). This study aims to describe the characteristics and outcomes of patients who received HFNC in the observation unit.
methodsWe performed a retrospective chart review of all patients admitted to a community pediatric observation unit who received HFNC between October 2022 and January 2023. Patients were grouped by disposition from the observation unit, either discharged home or transferred to PICU. Descriptive analysis was conducted, presented as median and interquartile range (IQR) or number and percentage.
resultsAmong 18 patients, 6 patients were discharged from the POU and 12 were transferred to the PICU, with an escalation rate of 66.6%. The most common pathogens in the sample were RSV (10 [55.5%]) and influenza (5 [27.8%]). Final diagnoses included bronchiolitis (8 [44.4%]), pneumonia (6 [33.3%]), bronchiolitis with secondary pneumonia (3 [16.7%]), and asthma exacerbation (1 [5.6%]). Median length of stay in the observation unit was 33.9 h (IQR 16.5–48.8). 4 of the 12 patients transferred to the PICU required higher forms of respiratory support, but none required intubation. There were no deaths in our sample, and no patients returned to the emergency department within 7 days of discharge. 293.2 PICU-bed-hours were saved.
conclusionsIn this study, several patients were able to be de-escalated from HFNC in a community pediatric observation unit setting without severe complications, including a zero-intubation rate. In a resource-strained setting, managing patients on HFNC in an observation unit may be a reasonable alternative to conserve PICU resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.